Full Text View
Tabular View
No Study Results Posted
Related Studies
A 10-Week Study Evaluating the Efficacy and Safety of PD 0332334 in Patients With Generalized Anxiety Disorder (1)
This study has been terminated.
( Please see Detailed Description for termination reason. )
Study NCT00658008   Information provided by Pfizer
First Received: April 8, 2008   Last Updated: June 18, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Generalized Anxiety Disorder
Additional conditions recognized in this trial
Anxiety Disorders
Disease
More general conditions related to this trial
Mental Disorders
Pathologic Processes
Interventions listed in this trial
PD 0332334
Paroxetine
Placebo
More general drug interventions related to this trial
Antidepressive Agents
Antidepressive Agents, Second-Generation
Central Nervous System Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Serotonin Agents
Serotonin Uptake Inhibitors
Therapeutic Uses
Sponsors listed in this trial
Pfizer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services